Ovarian Cancer Continues to Challenge Researchers - Multinational Clinical Trial Underway
Posted on March 13, 2008
According to the American Cancer Society, more than 22,000 cases of ovarian cancer will be diagnosed this year, and 15,000 women will die from it. More common in women over 55, there is about a one in 69 chance that a woman will contract ovarian cancer during her lifetime. Ovarian cancer remains the fifth leading cause of cancer deaths among women, and though it is a survivable disease, early detection is vital.
If detected and treated before it spreads past the ovaries, 93 percent of women will live longer than five years. Unfortunately, only about 20 percent of the cases are caught before this crucial stage. Fewer than half of women diagnosed with ovarian cancer will survive beyond those five years.
Ovarian cancer frequently becomes resistant to standard chemotherapy drugs, which is known as “chemoresistance.” Chemoresistance makes it difficult to successfully manage and treat ovarian cancer.
A Proactive Approach Towards Detection
Although ovarian cancer was once coined “the silent killer,” today, increased knowledge regarding what symptoms to look out for has made it easier for women to detect the cancer in its earliest stages.
According to the Ovarian Cancer National Alliance (OCNA), some symptoms appear much more frequently in women with ovarian cancer than other women. These symptoms include bloating, pelvic or abdominal pain, difficulty eating or feeling full quickly, and urinary problems such as excessive urgency or frequency.
OCNA encourages women to see a doctor, preferably a gynecologist, if they experience these symptoms almost daily for more than a few weeks or simply feel abnormal. Women with family histories that include cancer should be especially alert to these types of changes in their bodies. “Better safe than sorry” is the idea, and doctors will conduct pelvic exams, blood tests and transvaginal ultrasounds to look for ovarian cancer.
Once diagnosed, treatments vary widely. Depending on what stage the cancer is in, treatments can include surgery, chemotherapy, radiation therapy or investigational treatments in clinical trials. Phenoxodiol, one investigational (experimental) drug researchers are studying, is currently beginning Phase III of the clinical trial process. Phenoxodiol, which has designated “Fast Track” status by the U.S. Food and Drug Administration, is believed to help chemotherapy drugs, such as carboplatin, kill chemoresistant cancer cells by removing factors in the cells that block the killing action of chemotherapy. In laboratory studies, phenoxodiol has demonstrated that cancer cells pretreated with phenoxodiol were killed with lower doses of chemotherapy drugs. Importantly, phenoxodiol has been shown not to adversely affect normal cells in animal and laboratory testing.
A clinical trial called “OVATURE,” for OVArian TUmor REsponse, is underway to evaluate the safety and effectiveness of phenoxodiol. The trial, which aims to recruit 470 patients, is being conducted at clinical sites in the U.S., Europe and Australia. Researchers hope that when used in conjunction with chemotherapy (carboplatin), phenoxodiol will battle the cancer better than the chemotherapy can on its own.
In 2007, the National Institutes of Health will invest $106 million in ovarian cancer research. Yet despite continual advances in medicine, ovarian and other cancers remain difficult to detect and treat. It remains important for women to be alert to changes in their bodies and maintain a willingness to take action when something doesn’t feel right. While perhaps ovarian cancer can no longer be called a “silent killer,” it is still a quiet one. Increased awareness and more research are keys to helping women fight this deadly disease.
For more information on the OVATURE trial, visit http://www.OVATUREtrial.com
Article Author :Jonathan_David
Last 6 posts in Ovarian Cervical Uterine Cancer
- What is Vaginal Cancer? - July 6th, 2008
- What is Ovarian Cancer? - July 6th, 2008
- What is Cervical Cancer? - July 6th, 2008
- Uterine Cancer and Early Detection - July 6th, 2008
- Circumcision And Cervical Cancer - June 18th, 2008
- Why Uterine Cancer Isn't Caught Earlier - June 5th, 2008
- Study Vouches Triamazon's Efficacy In Selective Destruction Of Cancer Cells - May 27th, 2008
- Treated Cervical Cancer Which is Caused By HPV - May 27th, 2008
- The Stages of Endometriosis - May 21st, 2008
- Your Alternatives To The Gardasil - HPV Vaccine - May 21st, 2008
If you do your research, you’ll find that the information given still points to the “I don’t know, but here are the risk factors” lame explanation. What a lot of you know what! Sometimes I wonder if the people who write these things really think it through.
Here’s what I mean… “most women who develop breast cancer have no risk factors other than simply being a woman and getting older (especially being over 50). Talk to your doctor about your risk… blah, blah, blah.
Wouldn’t a better explanation be… “most women who develop breast cancer have no risk factors other than simply… Continue reading
Since most women today are quite aware of breast cancer and self testing, there are still many who only have a general knowledge of the symptoms of breast cancer. Knowing what to look for when suspecting you might have breast cancer, may save your life!
So let’s begin with what most women have become accustomed to doing, that is checking for lumps in their breast and the armpits. However, keep in mind that lumps in the breast does not necessarily mean you have breast cancer. Actually, they’re very common especially during menstruation, but doesn’t mean you have breast cancer.
Most often breast… Continue reading
If you were to look up “breast” in the dictionary, you’d find that it relates to the chest area. The reason for such a broad definition is that both males and females have chests and hence breasts, and both males and females can get breast cancer.
The difference, however, between male and female breast cancers and why women are more at risk of developing breast cancer is because of their make-up. Womens breasts is a gland designed to make milk. The lobules in the breast make the milk, which then drains through the ducts to the nipple.
Like all parts of your… Continue reading
Related posts
» Filed Under Ovarian Cervical Uterine Cancer
Comments
Leave a Reply
